19/01/2026
Could an ’s drug improve sickle cell disease ( ) care? New research says yes!
Findings published by the University of Zurich (UZH) - Universität Zürich point to a promising new approach in the of sickle cell anaemia. Researchers explored the effects of , a medication long approved and widely used for Alzheimer’s disease, to assess whether it could help reduce associated with SCD.
What makes this research especially relevant is memantine’s and . The drug is inexpensive, easy to store, and already available in many , features that could offer meaningful benefits for low- and middle-income countries, where SCD burden remains the highest.
👉 Read more about the study via the link in the comments.